Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors from the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advancements review located that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide av... https://jackp603qzg7.blog5star.com/profile